G. Starita Fajardo , D. Lucena López , C. Arévalo-Cañas , A. González García
{"title":"Enfermedad relacionada con IgG4","authors":"G. Starita Fajardo , D. Lucena López , C. Arévalo-Cañas , A. González García","doi":"10.1016/j.med.2025.04.020","DOIUrl":null,"url":null,"abstract":"<div><div>IgG4-related disease (IgG4-RD) is an immune-mediated disorder of a fibroinflammatory nature that can affect practically any organ. Some of the most common manifestations are glandular involvement, orbital pseudotumor, pancreatic involvement, and retroperitoneal fibrosis. The 2019 ACR/EULAR classification criteria for IgG4-RD, based on clinical and histologic findings, may be useful for diagnosis. Corticosteroids are the mainstay of treatment, although different immunosuppressive drugs are under investigation with mixed results.</div></div>","PeriodicalId":100912,"journal":{"name":"Medicine - Programa de Formación Médica Continuada Acreditado","volume":"14 31","pages":"Pages 1861-1870"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine - Programa de Formación Médica Continuada Acreditado","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304541225000939","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
IgG4-related disease (IgG4-RD) is an immune-mediated disorder of a fibroinflammatory nature that can affect practically any organ. Some of the most common manifestations are glandular involvement, orbital pseudotumor, pancreatic involvement, and retroperitoneal fibrosis. The 2019 ACR/EULAR classification criteria for IgG4-RD, based on clinical and histologic findings, may be useful for diagnosis. Corticosteroids are the mainstay of treatment, although different immunosuppressive drugs are under investigation with mixed results.